MAGI3 and nonpapillary renal cell carcinoma: These results establish a significant association between reduced MAGI3 levels (M/L) and an unfavorable prognosis in ccRCC patients, revealing MAGI3 as a promising novel prognostic marker and providing insights into its pivotal role in ccRCC initiation and progression.